Navigation Links
Danai Brooks Joins Dyadic International as Chief Operating Officer
Date:5/7/2013

JUPITER, Fla., May 7, 2013 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the industrial enzyme, bioenergy, and biopharmaceutical industries, announced today that Danai Brooks will join the Company as Executive Vice President and Chief Operating Officer in June.  Brooks joins Dyadic from J.P. Morgan where he served as a Vice President in the firm's Investment Bank.

(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO )

"Danai has significant financial and operational experience in the renewable energy and bio-based chemical space, and will be a tremendous asset to Dyadic," said Mark Emalfarb , Dyadic's President and Chief Executive Officer.  "As EVP and COO, Danai will play a key role in driving our business development and licensing efforts, as well as corporate strategic planning and operational improvements across the globe."

"As a long-time advisor to Dyadic, I am intimately familiar with the Company and thrilled to have the opportunity to join the team," said Brooks.  "Dyadic continues to compete with larger industrial enzyme companies using its game-changing C1 enzyme expression platform.  Together, we will continue to build commercial momentum through enzyme sales and strategic partnerships across a wide range of sectors including cellulosic biofuels, biopharmaceuticals and industrial applications.  We look forward to introducing new C1-based products to the many industries and companies that can benefit from C1's ability to produce enzymes and other proteins with class leading performance."

While at J.P. Morgan, Brooks advised clients across a broad spectrum of sectors, including chemica
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
2. Eastern Clinical Trials Russia-CEE Joins BIOCOM CRO
3. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
4. David Hooper Joins Evolution Marketing Research as Senior Director, Research
5. Full Service CRO DAaCRO Joins Salimetrics Center of Excellence Program
6. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
7. Revolutionary new device joins world of smart electronics
8. Jerry Adams Joins VIC Technology Venture Development Board of Directors
9. Noted Atherosclerosis Researcher Joins AtheroNova Team
10. Foundation For the NIH Joins NIH In Seeking Proposals to Study Sports-Related Brain Injuries
11. Leo Gingras Joins Nutraceutical Innovations, LLC Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2014)... , Nov. 17, 2014 Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today the formation of a Medical ... to the Company as it advances the Phase ... the treatment of cutaneous T-cell lymphoma (CTCL), a ...
(Date:11/15/2014)... MA (PRWEB) November 13, 2014 Collaborative ... announced they were named one of the Boston Globe’s ... the Medium Sized Businesses in Massachusetts to receive the ... honors employers who take care of their most valuable ... awards are presented annually, and are based on an ...
(Date:11/15/2014)... The International Society for Cardiovascular ... society’s Governing Board has grown with the additions ... officer and Dr. Charles Simonton, divisional vice president, ... Mr. Rowe and Dr. Simonton are both medical ... , Dr. Nabil Dib, ISCTR President stated, “We ...
(Date:11/15/2014)... November 14, 2014 The "Operating ... Surgical, Performance), by Application (Perioperative, Preoperative, operating room ... (Web-Based, On-Premise) - Global Forecast to 2019.” defines ... an analysis and forecast of value by product, ... Along with this, the value and volumes of ...
Breaking Biology Technology:Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6Collaborative Consulting Honored with Boston Globe Top Places to Work 2014 2International Society for Cardiovascular Translational Research Governing Board Adds Medical Industry Leaders 2Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 2Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 3Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 4
... WA, March 10 /PRNewswire-FirstCall/ - Oncothyreon Inc.,(Nasdaq: ONTY ... the year and quarter ended December 31, 2007. All ... Net loss for the year ended December 31, ... share, compared with $36.4 million, or $2.38,per basic and ...
... (Nasdaq: MNKD ) today issued the following ... is absolutely committed to the continued development of ... small,patient-friendly Medtone(R) inhaler to deliver Technosphere(R) Insulin to,patients ... closely matches the pattern,of insulin secretion seen in ...
... - Dr. Brad Thompson, President,and CEO of Oncolytics ... a,corporate overview of the Company at the BioSquare ... is being held at the Congress Center in,Basel, ... Biotech Inc., Oncolytics is a Calgary-based biotechnology ...
Cached Biology Technology:Oncothyreon reports full year and fourth quarter 2007 financial results 2Oncothyreon reports full year and fourth quarter 2007 financial results 3Oncothyreon reports full year and fourth quarter 2007 financial results 4Oncothyreon reports full year and fourth quarter 2007 financial results 5Oncothyreon reports full year and fourth quarter 2007 financial results 6Oncothyreon reports full year and fourth quarter 2007 financial results 7MannKind Corporation Response to Recent Market Events 2MannKind Corporation Response to Recent Market Events 3MannKind Corporation Response to Recent Market Events 4MannKind Corporation Response to Recent Market Events 5MannKind Corporation Response to Recent Market Events 6Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008 2
(Date:11/4/2014)... November 4, 2014   ... growth   Fuel3D , a developer of ... funding round totaling $6.4 million (£4 million). This funding builds ... earlier this year and paves the way for the commercial ... The funding round was led by Chimera Partners and ...
(Date:11/4/2014)... Lithuania , Nov. 4, 2014   ... technologies, today announced that the latest version of ... in the Ongoing MINEX evaluation organized ... of fingerprint algorithms using the INCITS 378 fingerprint ... mandatory requirement in public tenders in ...
(Date:11/3/2014)... University of Colorado Cancer Center study published ... of Sciences describes the activity of a recently ... 37 or IL-37. It has been known to limit ... the adaptive immune system: IL-37 inhibits the ability of ... , "Knowing this mechanism that underlies IL-37,s effect on ...
Breaking Biology News(10 mins):Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3PNAS: From HIV to cancer, IL-37 regulates immune system 2
... Vegas, NVCONRAD, a leading reproductive health research organization, will announce ... at the Reproductive Health 2011 Conference in Las Vegas, Nevada. ... implemented at six clinical sites in the U.S. showed that ... similar to traditional diaphragms. In addition, SILCS was ...
... -- Decreasing expression of a protein associated with susceptibility ... while improving their hormonal response to stress, a study ... found. The lack of this protein, FKBP51, did not ... The study suggests that drug discovery efforts aimed ...
... MD The Federation of American Societies for Experimental ... client, the Histochemical Society (HCS). The executive leadership ... include general management support, membership marketing, recruitment, and retention, ... Executive Director of HCS, William Stahl, PhD commented, "HCS ...
Cached Biology News:CONRAD presents results of pivotal contraceptive study at Reproductive Health 2011 2CONRAD presents results of pivotal contraceptive study at Reproductive Health 2011 3Lack of protein FKBP51 in old mice improves resilience to depressive behavior 2
...
... Anti-HMGN2/HMG-17 Immunogen : ... Tris-glycine, pH7.4, 5mg/ml BSA, 0.15M ... the addition of glycerol to ... by immunoblot on acid extracts ...
...
... different human fetal normal tissues are ... upon request. Customers can choose ... set, and pay 70% of the ... P Set products are for research ...
Biology Products: